The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Share News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.20
Bid: 12.90
Ask: 13.50
Change: 0.00 (0.00%)
Spread: 0.60 (4.65%)
Open: 13.20
High: 13.20
Low: 13.20
Yest. Close: 13.20
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

IN BRIEF: Yourgene wins two tenders for national framework contract

Mon, 26th Apr 2021 14:22

Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Says it has won two further tenders for national framework contracts, valued at a total of GBP4 billion. Yourgene says it was successful with its tenders under Public Health England's National Microbiology Framework for lot 2, covering research & development goods and services, and lot 3, covering manufacturing, product development and commercialisation. Lot 2 is a GBP1.5 billion framework to be satisfied over two years by multiple successful bidders, while lot 3 is a GBP2.5 billion framework over two years with 9 suppliers appointed.

The PHE tender was opened in November last year and sought to appoint suppliers to a multi-lot national microbiology framework agreement. Yourgene has been successful in all four of these lots and is one of only three companies to do so.

"Over the last year we have built up an infectious disease business with an impressive testing capacity and a best-in-class product, and have done so without taking our focus away from our core business", says Yourgene Chief Executive Lyn Rees.

"We are now well positioned to compete for the next wave of contracts under this framework, particularly as one of only three companies successful in all four lots. We believe this has been the right approach to deliver value to our shareholders as we continue to deliver year-on-year revenue growth and position ourselves strongly in both the private and government testing markets over the next two years."

Current stock price: 14.45p, up 4.3% on Monday afternoon

Year-to-date change: down 2.0%

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

18 Jun 21 13:23

Yourgene awarded supply contract with NHS Wales

(Sharecast News) - Molecular diagnostics group Yourgene Health has secured a contract to supply its Elucigene DPYD testing kits to NHS Wales.

18 Jun 21 09:17

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

9 Jun 21 14:09

Yourgene inks agreement with US-based precision medicine company

(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.

9 Jun 21 09:58

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

19 May 21 19:33

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

18 May 21 19:15

MyHealthChecked seals second Covid-19 test contract with Boots

MyHealthChecked seals second Covid-19 test contract with Boots

17 May 21 10:56

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

29 Apr 21 14:34

IN BRIEF: Yourgene wins two tenders for national framework contract

IN BRIEF: Yourgene wins two tenders for national framework contract

26 Apr 21 14:22

Yourgene awarded two more PHE framework agreements

(Sharecast News) - Molecular diagnostics company Yourgene announced on Monday that Public Health England (PHE) has confirmed that it was successful with its tenders under PHE's National Microbiology Framework for 'Lot 2', for research and development goods and services, and 'Lot 3', for manufacturing, product development and commercialisation.

26 Apr 21 10:56

UPDATE: Yourgene wins further national framework contract award

UPDATE: Yourgene wins further national framework contract award

19 Apr 21 14:10

Yourgene wins national contract award for Covid-19 testing services

Yourgene wins national contract award for Covid-19 testing services

19 Apr 21 11:44

Yourgene awarded PHE diagnostics framework agreement

(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.

19 Apr 21 08:49

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

6 Apr 21 15:40

IN BRIEF: MyHealthChecked to sell Covid-19 tests in Boots stores

IN BRIEF: MyHealthChecked to sell Covid-19 tests in Boots stores

6 Apr 21 14:22

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.